Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines

6 Mar 2008

Abstract excerpt

The rapid spread of avian influenza (H5N1) and its transmission to humans has raised the possibility of an imminent pandemic and concerns over the ability of standard influenza vaccine production methods to supply sufficient amounts of an effective vaccine. We report here on a robust and flexible strategy which uses wild-type virus grown in a continuous cell culture (Vero) system to produce an inactivated whole...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Influenza Virus Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18953724
DOI: 10.1515/bc.2008.060

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccinesPMID 18953724Read ↗

Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine productionSemantic proximity Read ↗

A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.Semantic proximity Read ↗

Influenza vaccines: the potential benefits of cell-culture isolation and manufacturingSemantic proximity Read ↗

Immunization with a novel RNA replicon vaccine confers long-lasting protection against H5N1 avian influenza virus in 24 bird speciesSemantic proximity Read ↗

Development of high-yield influenza A virus vaccine viruses.Semantic proximity Read ↗

Poliovirus-nonsusceptible Vero cell line for the World Health Organization global action planSemantic proximity Read ↗

Immunogenicity and Efficacy Evaluation of Vero Cell-Adapted Infectious Bursal Disease Virus LC-75 Vaccine Strain in Ethiopia Semantic proximity Read ↗

Generation of High-Yielding Influenza A Viruses in African Green Monkey Kidney (Vero) Cells by Reverse GeneticsSemantic proximity Read ↗

Single dose of multi-clade virus-like particle vaccine protects chickens against clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza virusesSemantic proximity Read ↗

Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine developmentSemantic proximity Read ↗

Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved EffectivenessSemantic proximity Read ↗

A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza VirusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.